As part of a redevelopment of the 15th Floor, a new Cleanroom is to be constructed to serve the Hospital. The proposal aims to expand the current footprint of the Advanced Therapies Manufacturing Unit to include at least two additional Good Manufacturing Practice (GMP) compliant cleanrooms for the manufacture of gene and cell therapies for clinical trials.
Scope of Work:
- Cleanroom Expansion & Construction – Design, supply, installation, and commissioning of GMP-compliant cleanrooms and support areas.
- Increased GMP Manufacturing Capacity – Addition of two cleanrooms to enhance concurrent production and accelerate the availability of ATIMPs for patient administration.
- Optimised Research & Clinical Trial Efficiency – Faster data collection, earlier trial conclusions, and improved adaptation of ATIMPs for future studies.
Key Project Outcomes:
- Increased capacity for manufacturing multiple ATIMPs simultaneously, reducing time to patient administration.
- Enhanced reputation as a leading centre for ATIMP development and clinical trials.
- Expansion includes Grade C/D support areas with additional unclassified peripheral spaces.
- ACE is responsible for the design, supply, and installation of architectural elements within the facility.
This expansion reinforces the hospital’s position as a centre of excellence in ATIMP manufacturing and clinical trials, fostering innovation and accelerating advancements in gene and cell therapy.
